Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Aspen Neuroscience
AddedFeb 13, 2024
UpdatedJun 18, 2026
Aspen Neuroscience

Aspen Neuroscience

Series D

Aspen develops patient-specific therapies using innovative stem cell technology.

HQ
San Diego, CA, US
Founded
2018
Overview
Compare
Fundraising
Employees

Aspen Neuroscience is dedicated to developing patient-specific therapies using innovative stem cell technology. Their core mission is to harness the potential of induced pluripotent stem cells to create personalized treatments for neurological disorders. The company focuses on providing groundbreaking solutions for conditions like Parkinson's disease.

Aspen Neuroscience has made significant strides in the field of regenerative medicine, leveraging advanced stem cell research to offer hope for patients with debilitating neurological conditions. Their work has attracted attention from leading investors and experts in the biotech industry.

Aspen Neuroscience - Similar Companies

Convalesce logo

Convalesce

convalesce.co

APstem Therapeutics logo

APstem Therapeutics

apstemtx.com

Neuronascent logo

Neuronascent

neuronascent.com

Personalized Stem Cells logo

Personalized Stem Cells

Empyrean Neuroscience logo

Empyrean Neuroscience

empyrean.bio

NeyroblastGX logo

NeyroblastGX

neyroblastgx.com

Neurona Therapeutics logo

Neurona Therapeutics

Cell Reprogramming & Therapeutics logo

Cell Reprogramming & Therapeutics

Reservoir Neuroscience logo

Reservoir Neuroscience

reservoirneuro.com

Cellebration Life Sciences logo

Cellebration Life Sciences

Stemson Therapeutics logo

Stemson Therapeutics

stemsontx.com

ImStem Biotechnology logo

ImStem Biotechnology

imstem.com

Gate Neurosciences logo

Gate Neurosciences

gateneuro.com

I Peace logo

I Peace

Pipeline Therapeutics logo

Pipeline Therapeutics

Aspen Neuroscience - Quick Facts

Who are Aspen Neuroscience's competitors?

Companies similar to Aspen Neuroscience include Convalesce, APstem Therapeutics, Neuronascent and Personalized Stem Cells.

When was Aspen Neuroscience founded?

Aspen Neuroscience was founded in 2018.

Where is Aspen Neuroscience's headquarters located?

Aspen Neuroscience's headquarters is located in San Diego, CA, US.

When was Aspen Neuroscience's last funding round?

Aspen Neuroscience's most recent funding round was for $40M (USD) in December 2022.

How much has Aspen Neuroscience raised to-date?

As of Dec 21, 2022, Aspen Neuroscience has raised a total of $264M (USD).

How many employees does Aspen Neuroscience have?

Aspen Neuroscience has 112 employees as of Feb 4, 2024.

Aspen Neuroscience - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Stem Cell Therapies
Tags
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 9 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified